166 related articles for article (PubMed ID: 25202074)
61. Transcription inhibition of heat shock proteins: a strategy for combination of 17-allylamino-17-demethoxygeldanamycin and actinomycin d.
Cervantes-Gomez F; Nimmanapalli R; Gandhi V
Cancer Res; 2009 May; 69(9):3947-54. PubMed ID: 19383903
[TBL] [Abstract][Full Text] [Related]
62. Decreased heat shock protein 27 expression and altered autophagy in human cells harboring A8344G mitochondrial DNA mutation.
Chen CY; Chen HF; Gi SJ; Chi TH; Cheng CK; Hsu CF; Ma YS; Wei YH; Liu CS; Hsieh M
Mitochondrion; 2011 Sep; 11(5):739-49. PubMed ID: 21679777
[TBL] [Abstract][Full Text] [Related]
63. Tanespimycin and tipifarnib exhibit synergism in inducing apoptosis in melanoma cell lines from later stages of tumor progression.
Bentke A; Małecki J; Ostrowska B; Krzykowska-Petitjean K; Laidler P
Cancer Invest; 2013 Oct; 31(8):545-9. PubMed ID: 24066674
[TBL] [Abstract][Full Text] [Related]
64. Effect of HSP90 inhibitor in pheochromocytoma PC12 cells: an experimental investigation.
Xu Y; Zhang C; Chen D; Zhao J; Shen Z; Wu Y; Zhu Y
Tumour Biol; 2013 Dec; 34(6):4065-71. PubMed ID: 23873112
[TBL] [Abstract][Full Text] [Related]
65. [Heat shock protein 90--modulator of TNFalpha-induced apoptosis of Jurkat tumor cells].
Kaĭgorodova EV; Riazantseva NV; Novitskiĭ VV; Moroshkina AN; Belkina MV; Iakushina VD
Vestn Ross Akad Med Nauk; 2011; (8):3-6. PubMed ID: 21950128
[TBL] [Abstract][Full Text] [Related]
66. The apoptosis-resistance in t-AUCB-treated glioblastoma cells depends on activation of Hsp27.
Li J; Hu W; Lan Q
J Neurooncol; 2012 Nov; 110(2):187-94. PubMed ID: 22903412
[TBL] [Abstract][Full Text] [Related]
67. Stimulation of electroporation-induced inward currents in glioblastoma cell lines by the heat shock protein inhibitor AUY922.
Chiang NJ; Wu SN; Kao CA; Huang YM; Chen LT
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):830-7. PubMed ID: 24909268
[TBL] [Abstract][Full Text] [Related]
68. Anti-cancer effects of chemotherapeutic agent; 17-AAG, in combined with gold nanoparticles and irradiation in human colorectal cancer cells.
Moradi Z; Mohammadian M; Saberi H; Ebrahimifar M; Mohammadi Z; Ebrahimpour M; Behrouzkia Z
Daru; 2019 Jun; 27(1):111-119. PubMed ID: 30835081
[TBL] [Abstract][Full Text] [Related]
69. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.
Díaz-Chávez J; Fonseca-Sánchez MA; Arechaga-Ocampo E; Flores-Pérez A; Palacios-Rodríguez Y; Domínguez-Gómez G; Marchat LA; Fuentes-Mera L; Mendoza-Hernández G; Gariglio P; López-Camarillo C
PLoS One; 2013; 8(5):e64378. PubMed ID: 23724044
[TBL] [Abstract][Full Text] [Related]
70. Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management.
Rajesh Y; Banerjee A; Pal I; Biswas A; Das S; Dey KK; Kapoor N; Ghosh AK; Mitra P; Mandal M
Biochim Biophys Acta Gen Subj; 2019 Jul; 1863(7):1196-1209. PubMed ID: 31028823
[TBL] [Abstract][Full Text] [Related]
71. Flavopiridol's antiproliferative effects in glioblastoma multiforme.
Cobanoglu G; Turacli ID; Ozkan AC; Ekmekci A
J Cancer Res Ther; 2016; 12(2):811-7. PubMed ID: 27461656
[TBL] [Abstract][Full Text] [Related]
72. Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells.
Horibe T; Torisawa A; Kohno M; Kawakami K
Mol Cancer; 2012 Aug; 11():59. PubMed ID: 22913813
[TBL] [Abstract][Full Text] [Related]
73. Rosmarinic acid and siRNA combined therapy represses Hsp27 (HSPB1) expression and induces apoptosis in human glioma cells.
Şengelen A; Önay-Uçar E
Cell Stress Chaperones; 2018 Sep; 23(5):885-896. PubMed ID: 29627902
[TBL] [Abstract][Full Text] [Related]
74. Synthesis and biological effect of chrom-4-one derivatives as functional inhibitors of heat shock protein 27.
Hwang SY; Kwak SY; Kwon Y; Lee YS; Na Y
Eur J Med Chem; 2017 Oct; 139():892-900. PubMed ID: 28869891
[TBL] [Abstract][Full Text] [Related]
75. STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survival.
Chatterjee M; Jain S; Stühmer T; Andrulis M; Ungethüm U; Kuban RJ; Lorentz H; Bommert K; Topp M; Krämer D; Müller-Hermelink HK; Einsele H; Greiner A; Bargou RC
Blood; 2007 Jan; 109(2):720-8. PubMed ID: 17003370
[TBL] [Abstract][Full Text] [Related]
76. Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules.
Kim JH; Jung YJ; Choi B; Lee NL; Lee HJ; Kwak SY; Kwon Y; Na Y; Lee YS
Oncotarget; 2016 Aug; 7(33):53178-53190. PubMed ID: 27449291
[TBL] [Abstract][Full Text] [Related]
77. The chaperone system in glioblastoma multiforme and derived cell lines: diagnostic and mechanistic implications.
Alberti G; Campanella C; Paladino L; Porcasi R; Bavisotto CC; Pitruzzella A; Graziano F; Florena AM; Argo A; de Macario EC; Macario AJ; Cappello F; Bucchieri F; Barone R; Rappa F
Front Biosci (Landmark Ed); 2022 Mar; 27(3):97. PubMed ID: 35345329
[TBL] [Abstract][Full Text] [Related]
78. Depletion of thymopoietin inhibits proliferation and induces cell cycle arrest/apoptosis in glioblastoma cells.
Zhang L; Wang G; Chen S; Ding J; Ju S; Cao H; Tian H
World J Surg Oncol; 2016 Oct; 14(1):267. PubMed ID: 27756319
[TBL] [Abstract][Full Text] [Related]
79. Concomitant inhibition of HSP90, its mitochondrial localized homologue TRAP1 and HSP27 by green tea in pancreatic cancer HPAF-II cells.
Zhang L; Pang E; Loo RR; Rao J; Go VL; Loo JA; Lu QY
Proteomics; 2011 Dec; 11(24):4638-47. PubMed ID: 22116673
[TBL] [Abstract][Full Text] [Related]
80. The novel Hsp90 inhibitor NXD30001 induces tumor regression in a genetically engineered mouse model of glioblastoma multiforme.
Zhu H; Woolfenden S; Bronson RT; Jaffer ZM; Barluenga S; Winssinger N; Rubenstein AE; Chen R; Charest A
Mol Cancer Ther; 2010 Sep; 9(9):2618-26. PubMed ID: 20643786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
